Advertisement

Topics

Semafore Pharmaceuticals Inc. Company Profile

23:25 EST 4th December 2016 | BioPortfolio

Semafore is a clinical stage drug discovery and development company focused on small molecule modulators of the PI3 kinase and PTEN cell signaling pathway, a promising target pathway for multiple disorders, including the company's focus -- cancer. Semafore is a leader in the development of PI3K inhibitors and one of the first biopharmaceutical companies to focus on both PI3K and PTEN. The company has successfully discovered and is developing a portfolio of drug candidates addressing these targets.


News Articles [1391 Associated News Articles listed on BioPortfolio]

M&As this week: Scintilla Pharmaceuticals, Lonza Group Ltd, Piramal Enterprises Limited

Scintilla Pharmaceuticals has entered a binding term sheet to acquire Semnur Pharmaceuticals for a purchase consideration of up to $200m.

Easton Pharmaceuticals and Partner BMV Medica Announce Closing Of First Distribution Agreement For Three Exclusively Licensed Women's Health Products: VagiSense, AmnioSense and Gynofit With Windsor Pharmaceuticals For Central America and The Caribbean /

TORONTO, ON -- (Marketwired) -- 10/31/16 -- Easton Pharmaceuticals Inc. (OTC PINK: EAPH) announces it has closed its first Sales & Distribution agreement with Windsor Pharmaceuticals SA for three ...

Delisting and regulator's inaction failed to improve market capitalization of pharma entities

The Bombay Stock Exchange (BSE) authorities have suspended major companies from pharmaceutical segment like Elder Pharmaceuticals, Surya Pharmaceuticals, Plethico Pharmaceuticals, Twilight Litaka, Dr

BRIEF-Acetylon Pharmaceuticals entered into an agreement to be acquired by Celgene Corporation

* Acetylon Pharmaceuticals -Regenacy Pharmaceuticals to be launched by Acetylon Pharmaceuticals and Celgene Corporation agrees to complete acquisition of acetylon

Scintilla to Acquire SCILEX Pharmaceuticals

NewsScintilla Pharmaceuticals to acquire SCILEX Pharmaceuticals to add a late-stage asset to bolster its pain management business.

Pharmaceuticals: Global Industry Guide Prices from USD $1495

SummaryGlobal Pharmaceuticals industry guide provides topline qualitative and quantitative summary information including: market share, market size value , and forecast to 2019. The guide also contain...

M&As this week: Savara Pharma, Xiangxue Pharmaceuticals

Savara Pharmaceuticals plans to expand its pipeline of orphan respiratory drugs by acquiring Serendex Pharmaceuticals, a provider of inhalation therapies for rare respiratory conditions.

KalVista Pharmaceuticals, Inc.: KalVista Pharmaceuticals Announces Closing of Merger with Carbylan Therapeutics

-Combined company renamed KalVista Pharmaceuticals, Inc., listed on Nasdaq with ticker "KALV" - -Continued focus on development of protease inhibitors with multiple molecules for oral treatment of ...

Drugs and Medications [0 Results]

None

PubMed Articles [146 Associated PubMed Articles listed on BioPortfolio]

Biotransformation of pharmaceuticals by ammonia oxidizing bacteria in wastewater treatment processes.

Pharmaceutical residues could potentially pose detrimental effects on aquatic ecosystems and human health, with wastewater treatment being one of the major pathways for pharmaceuticals to enter into t...

Announcing the 2016 Pharmaceuticals Travel Award for Young Investigators.

For the first time in its short history, our journal is able, this year, to support a young researcher in the field of medicinal chemistry by offering a travel grant of 800 CHF.[...].

Photosynthetic sensitivity of phytoplankton to commonly used pharmaceuticals and its dependence on cellular phosphorus status.

Recently pharmaceuticals have become significant environmental pollutants in aquatic ecosystems, that could affect primary producers such as microalgae. Here we analyzed the effect of pharmaceuticals ...

Occurrence of pharmaceuticals and cocaine in a Brazilian coastal zone.

The present study determined environmental concentrations of pharmaceuticals, cocaine, and the main human metabolite of cocaine in seawater sampled from a subtropical coastal zone (Santos, Brazil). Th...

Fate of pharmaceuticals and pesticides in fly larvae composting.

A novel and efficient organic waste management strategy currently gaining great attention is fly larvae composting. High resource recovery efficiency can be achieved in this closed-looped system, but ...

Clinical Trials [20 Associated Clinical Trials listed on BioPortfolio]

Bioequivalence Study of Torrent Pharmaceuticals Ltd.'s Rosuvastatin Calcium Tablets Under Fed Conditions

Subjects to compare the single dose bioavailability of Torrent's Rosuvastatin Calcium Tablets 40 mg and Crestor® 40 mg Tablets of AstraZeneca Pharmaceuticals LP, USA. Dosing periods of st...

Study of Generic Pimecrolimus Cream, 1% in the Treatment of Mild to Moderate Atopic Dermatitis

This is a Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multiple-Site Study to Evaluate the Therapeutic Equivalence of a Generic Pimecrolimus Cream, 1% (Glenmark Pharmaceut...

Phase I Study to Evaluate the Effect of Food on the Pharmacokinetics of Dexibuprofen 300 mg.

To evaluate the interaction of food on the pharmacokinetics of Dexibuprofen 300 mg (Apsen Pharmaceuticals A / S.), after single dose oral administration to healthy subjects of both sexes, ...

Phase I Study to Evaluate the Effect of Food on the Pharmacokinetics of Dexibuprofen 200 mg.

To evaluate the interaction of food on the pharmacokinetics of Dexibuprofen 200 mg (Apsen Pharmaceuticals A / S.) after single dose oral administration to healthy subjects of both sexes, u...

Bioequivalence Study of Torrent Pharmaceuticals Ltd.'s Fluoxetine Tablet Under Fasting Conditions

Subjects to compare the single dose bioavailability of Torrent's Fluoxetine Tablets 20 mg and Sarafem® 20 mg Tablets of Warner Chilcott LLC, USA. Dosing periods of studies were separated ...

Companies [3 Associated Companies listed on BioPortfolio]

Semafore Pharmaceuticals Inc.

Semafore is a clinical stage drug discovery and development company focused on small molecule modulators of the PI3 kinase and PTEN cell signaling pathway, a promising target pathway for multiple ...

Semafore Pharmaceuticals

Semafore Pharmaceuticals is a private, clinical-stage biotechnology company dedicated to the discovery and development of novel small molecule signal transduction inhibitors targe...

Semafore Pharmaceuticals, Inc.

Founded in 2000, Semafore Pharmaceuticals is a clinical-stage biotechnology company dedicated to the discovery and development of novel small molecule signal transduction inhibito...

More Information about "Semafore Pharmaceuticals Inc." on BioPortfolio

We have published hundreds of Semafore Pharmaceuticals Inc. news stories on BioPortfolio along with dozens of Semafore Pharmaceuticals Inc. Clinical Trials and PubMed Articles about Semafore Pharmaceuticals Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Semafore Pharmaceuticals Inc. Companies in our database. You can also find out about relevant Semafore Pharmaceuticals Inc. Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topics

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...


Corporate Database Quicklinks



Searches Linking to this Company Record